1. |
Dalén BP, Bergh PM, Gunterberg BU. Desmoid tumors: a clinical review of 30 patients with more than 20 years’ follow-up. Acta Orthop Scand, 2003, 74(4): 455-459.
|
2. |
Mueller J. Ueber den feineren bau und die formender krankhaften geschwulste. Berlin: G. Reimer, 1838: 60.
|
3. |
Jo VY, Fletcher CD. WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology, 2014, 46(2): 95-104.
|
4. |
van Broekhoven DL, Grünhagen DJ, den Bakker MA, et al. Time trends in the incidence and treatment of extra-abdominal and abdominal aggressive fibromatosis: a population-based study. Ann Surg Oncol, 2015, 22(9): 2817-2823.
|
5. |
Rampone B, Pedrazzani C, Marrelli D, et al. Updates on abdominal desmoid tumors. World J Gastroenterol, 2007, 13(45): 5985-5988.
|
6. |
Ballo MT, Zagars GK, Pollack A, et al. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol, 1999, 17(1): 158-167.
|
7. |
Zlotecki RA, Scarborough MT, Morris CG, et al. External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis. Int J Radiat Oncol Biol Phys, 2002, 54(1): 177-181.
|
8. |
Posner MC, Shiu MH, Newsome JL, et al. The desmoid tumor. Not a benign disease. Arch Surg, 1989, 124(2): 191-196.
|
9. |
Hatzimarkou A, Filippou D, Papadopoulos V, et al. Desmoid tumor in Gardner’s Syndrome presented as acute abdomen. World J Surg Oncol, 2006, 4: 18.
|
10. |
Kasper B, Ströbel P, Hohenberger P. Desmoid tumors: clinical features and treatment options for advanced disease. Oncologist, 2011, 16(5): 682-693.
|
11. |
Clark SK, Phillips RK. Desmoids in familial adenomatous polyposis. Br J Surg, 1996, 83(11): 1494-1504.
|
12. |
Ihalainen HR, Koljonen V, Böhling TO, et al. The desmoid tumour: local control after surgical treatment. J Plast Surg Hand Surg, 2015, 49(1): 19-24.
|
13. |
Tolan S, Shanks JH, Loh MY, et al. Fibromatosis: benign by name but not necessarily by nature. Clin Oncol (R Coll Radiol), 2007, 19(5): 319-326.
|
14. |
Faria SC, Iyer RB, Rashid A, et al. Desmoid tumor of the small bowel and the mesentery. AJR Am J Roentgenol, 2004, 183(1): 118.
|
15. |
Nakayama T, Tsuboyama T, Toguchida J, et al. Natural course of desmoid-type fibromatosis. J Orthop Sci, 2008, 13(1): 51-55.
|
16. |
Lazar AJ, Hajibashi S, Lev D. Desmoid tumor: from surgical extirpation to molecular dissection. Curr Opin Oncol, 2009, 21(4): 352-359.
|
17. |
刘啸峰, 丁玉芹, 何德明, 等. 腹内型侵袭性纤维瘤病多排螺旋 CT 和 MRI 诊断价值. 蚌埠医学院学报, 2015, 40(2): 238-241.
|
18. |
Kamali F, Wang WL, Guadagnolo BA, et al. MRI may be used as a prognostic indicator in patients with extra-abdominal desmoid tumours. Br J Radiol, 2016, 89(1058): 20150308.
|
19. |
He XD, Zhang YB, Wang L, et al. Prognostic factors for the recurrence of sporadic desmoid-type fibromatosis after macroscopically complete resection: analysis of 114 patients at a single institution. Eur J Surg Oncol, 2015, 41(8): 1013-1019.
|
20. |
Fiore M, Rimareix F, Mariani L, et al. Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol, 2009, 16(9): 2587-2593.
|
21. |
Mullen JT, Delaney TF, Kobayashi WK, et al. Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series. Ann Surg Oncol, 2012, 19(13): 4028-4035.
|
22. |
Crago AM, Denton B, Salas S, et al. A prognostic nomogram for prediction of recurrence in desmoid fibromatosis. Ann Surg, 2013, 258(2): 347-353.
|
23. |
Ergen ŞA, Tiken EE, Öksüz DÇ, et al. The role of radiotherapy in the treatment of primary or recurrent desmoid tumors and long-term results. Balkan Med J, 2016, 33(3): 316-321.
|
24. |
Lev D, Kotilingam D, Wei C, et al. Optimizing treatment of desmoid tumors. J Clin Oncol, 2007, 25(13): 1785-1791.
|
25. |
Ballo MT, Zagars GK, Pollack A. Radiation therapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys, 1998, 42(5): 1007-1014.
|
26. |
Park KH, Choi YJ, Kim KW, et al. Combination chemotherapy with methotrexate and vinblastine for surgically unresectable, aggressive fibromatosis. Jpn J Clin Oncol, 2016, 46(9): 845-849.
|